SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 196 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $990,000 | +6.3% | 55,163 | -30.1% | 0.00% | – |
| Q3 2017 | $931,000 | +12.4% | 78,864 | 0.0% | 0.00% | – |
| Q2 2017 | $828,000 | -4.6% | 78,864 | 0.0% | 0.00% | – |
| Q1 2017 | $868,000 | -54.5% | 78,864 | -54.8% | 0.00% | -100.0% |
| Q1 2016 | $1,907,000 | -43.3% | 174,505 | -10.3% | 0.00% | 0.0% |
| Q4 2015 | $3,362,000 | +15.7% | 194,436 | +33.0% | 0.00% | 0.0% |
| Q3 2015 | $2,906,000 | +28.1% | 146,231 | +5.9% | 0.00% | 0.0% |
| Q2 2015 | $2,268,000 | +14.7% | 138,021 | +8.6% | 0.00% | 0.0% |
| Q1 2015 | $1,978,000 | +2435.9% | 127,121 | +963.6% | 0.00% | – |
| Q3 2014 | $78,000 | -6.0% | 11,952 | 0.0% | 0.00% | – |
| Q2 2014 | $83,000 | -73.3% | 11,952 | -72.6% | 0.00% | – |
| Q1 2014 | $311,000 | -23.4% | 43,552 | +0.8% | 0.00% | – |
| Q4 2013 | $406,000 | +49.3% | 43,203 | -1.0% | 0.00% | – |
| Q3 2013 | $272,000 | -3.2% | 43,659 | +2.2% | 0.00% | – |
| Q2 2013 | $281,000 | – | 42,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 555,652 | $9,607,000 | 3.06% |
| OBERWEIS ASSET MANAGEMENT INC/ | 96,630 | $1,671,000 | 0.47% |
| JUNCTURE WEALTH STRATEGIES, LLC | 35,281 | $610,000 | 0.46% |
| AWM Investment Company, Inc. | 100,000 | $1,729,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 65,588 | $1,134,000 | 0.30% |
| NEW AMSTERDAM PARTNERS LLC/NY | 166,479 | $2,878,000 | 0.30% |
| Convergence Investment Partners, LLC | 100,850 | $1,744,000 | 0.20% |
| GSA CAPITAL PARTNERS LLP | 219,881 | $3,802,000 | 0.19% |
| OXFORD ASSET MANAGEMENT LLP | 433,219 | $7,672,000 | 0.18% |
| Zebra Capital Management LLC | 17,720 | $306,000 | 0.17% |